Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anetta Undas

Showing results (431-440 of 652) with videos related to

Pageof 66
Sort By:
Archives of Medical Science : AMS|October 4, 2016
Activated factor IX, factor XI and tissue factor identify patients with permanent atrial fibrillation treated with warfarin who are at risk of ischemic strokePiotr Kusak, Danuta Czarnecka, Matthew Gissel, et al.
Polish Archives of Internal Medicine|July 24, 2025
The 2023 ACR/EULAR classification criteria for antiphospholipid syndrome in patients with atrial fibrillation: effect on prothrombotic and fibrinolysis markersMaksymilian Hanarz, Joanna Natorska, Joanna Ochotnicka, et al.
Polish Archives of Internal Medicine|February 26, 2026
Prothrombotic fibrin clot phenotype in obstetric antiphospholipid syndrome: clinical implications and unanswered questions. Authors' replyMagdalena Piróg, Michał Ząbczyk, Joanna Natorska, et al.
Journal of Thrombosis and Thrombolysis|November 6, 2023
Reduced fibrin clot permeability on admission and elevated E-selectin at 3 months as novel risk factors of residual pulmonary vascular obstruction in patients with acute pulmonary embolismKonrad Stępień, Michał Ząbczyk, Magdalena Kopytek, et al.
Journal of Cardiovascular Pharmacology|May 12, 2011
Ezetimibe combined with simvastatin compared with simvastatin alone results in a greater suppression of oxidative stress and enhanced fibrinolysis in patients after acute coronary eventsAnetta Undas, Andrzej Machnik, Daniel P Potaczek, et al.
Thrombosis Research|August 17, 2010
Plasma factor and inhibitor composition contributes to thrombin generation dynamics in patients with acute or previous cerebrovascular eventsMatthew Gissel, Anetta Undas, Agnieszka Slowik, et al.
International Journal of Cardiology|March 7, 2021
Right ventricular echocardiographic parameters associated with prothrombotic abnormalities in normotensive patients with acute pulmonary embolismAgnieszka Janion-Sadowska, Paweł Rostoff, Michał Ząbczyk, et al.
Genes|May 28, 2022
A Series of 14 Polish Patients with Thrombotic Events and PC Deficiency-Novel c.401-1G>A PROC Gene Splice Site Mutation in a Patient with AneurysmsAnna Weronska, Daniel P Potaczek, Julia Oto, et al.
Thrombosis and Haemostasis|May 30, 2006
Effects of simvastatin on angiogenic growth factors released at the site of microvascular injuryAnetta Undas, Magdalena Celińska-Lowenhoff, Ewa Stepień, et al.
Plos One|November 6, 2015
Unfavorably Altered Fibrin Clot Properties in Patients with Eosinophilic Granulomatosis with Polyangiitis (Churg-Strauss Syndrome): Association with Thrombin Generation and EosinophiliaLucyna Mastalerz, Magdalena Celińska-Lӧwenhoff, Piotr Krawiec, et al.
Pageof 66

Showing results (431-440 of 652) with videos related to

Sort By:
Pageof 66
Archives of Medical Science : AMS|October 4, 2016
Activated factor IX, factor XI and tissue factor identify patients with permanent atrial fibrillation treated with warfarin who are at risk of ischemic strokePiotr Kusak, Danuta Czarnecka, Matthew Gissel, et al.
Polish Archives of Internal Medicine|July 24, 2025
The 2023 ACR/EULAR classification criteria for antiphospholipid syndrome in patients with atrial fibrillation: effect on prothrombotic and fibrinolysis markersMaksymilian Hanarz, Joanna Natorska, Joanna Ochotnicka, et al.
Polish Archives of Internal Medicine|February 26, 2026
Prothrombotic fibrin clot phenotype in obstetric antiphospholipid syndrome: clinical implications and unanswered questions. Authors' replyMagdalena Piróg, Michał Ząbczyk, Joanna Natorska, et al.
Journal of Thrombosis and Thrombolysis|November 6, 2023
Reduced fibrin clot permeability on admission and elevated E-selectin at 3 months as novel risk factors of residual pulmonary vascular obstruction in patients with acute pulmonary embolismKonrad Stępień, Michał Ząbczyk, Magdalena Kopytek, et al.
Journal of Cardiovascular Pharmacology|May 12, 2011
Ezetimibe combined with simvastatin compared with simvastatin alone results in a greater suppression of oxidative stress and enhanced fibrinolysis in patients after acute coronary eventsAnetta Undas, Andrzej Machnik, Daniel P Potaczek, et al.
Thrombosis Research|August 17, 2010
Plasma factor and inhibitor composition contributes to thrombin generation dynamics in patients with acute or previous cerebrovascular eventsMatthew Gissel, Anetta Undas, Agnieszka Slowik, et al.
International Journal of Cardiology|March 7, 2021
Right ventricular echocardiographic parameters associated with prothrombotic abnormalities in normotensive patients with acute pulmonary embolismAgnieszka Janion-Sadowska, Paweł Rostoff, Michał Ząbczyk, et al.
Genes|May 28, 2022
A Series of 14 Polish Patients with Thrombotic Events and PC Deficiency-Novel c.401-1G>A PROC Gene Splice Site Mutation in a Patient with AneurysmsAnna Weronska, Daniel P Potaczek, Julia Oto, et al.
Thrombosis and Haemostasis|May 30, 2006
Effects of simvastatin on angiogenic growth factors released at the site of microvascular injuryAnetta Undas, Magdalena Celińska-Lowenhoff, Ewa Stepień, et al.
Plos One|November 6, 2015
Unfavorably Altered Fibrin Clot Properties in Patients with Eosinophilic Granulomatosis with Polyangiitis (Churg-Strauss Syndrome): Association with Thrombin Generation and EosinophiliaLucyna Mastalerz, Magdalena Celińska-Lӧwenhoff, Piotr Krawiec, et al.
Pageof 66